Researchers described a vancomycin-resistant Enterococcus infection transmitted from a liver donor to recipient, ruling out hospital-acquired infection with genomics.
The firm said that its metagenomic sequencing-based service provides a broad scope of pathogen testing for people with chronic medical conditions.
Both companies plan to offer the test to researchers and clinicians to help better determine when a patient can be diagnosed with an infectious disease.
Targeted sequencing on isolates collected in Saudi Arabia led to 16 rare, non-tuberculosis Mycobacterium species from individuals with lung or other infections.
Researchers from the CDC and Georgia Tech tested the efficacy of using whole-genome shotgun sequencing to diagnose food-borne pathogens in outbreaks.
In PLOS this week: ramifications of multi-nucleotide de novo mutations, circulating microRNAs and atrial fibrillation, and more.
The company attributed the fall in revenues to decreased sales of rapid pathogen identification and legacy genome mapping products.
Researchers from the diagnostics company will work with researchers from the microbial genomics lab of George Weinstock.
The firm's approach to sepsis is at the core of its infectious disease testing strategy with MDx, biomarker tests, and mass spec technologies all playing a role.
The company is also developing a next-generation sequencing product that may be applied at the point of need to test for bloodstream infections and later as a liquid biopsy for cancer.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.